Nicotinamide mononucleotide (NMN) is a biologically active nucleotide that exists naturally in all forms of life. It is composed of nicotinamide (NAM) and ribose connected by a phosphate bond. It participates in the biosynthesis of nicotinamide adenine dinucleotide (NAD⁺) in cells and plays a key role in maintaining normal cell function and metabolism.

From the basic information, the chemical formula of NMN is \(C_{11}H_{15}N_{2}O_{8}P\), and the molecular weight is about 334.22 g/mol. It usually appears as a white to light yellow powder, and this physical form makes it easier to handle during storage and use.

In terms of physical and chemical properties, NMN is easily soluble in water, which enables it to dissolve quickly in the aqueous environment of the organism and participate in various biochemical reactions. Its chemical stability is relatively good, but under extreme conditions such as high temperature, high humidity or strong acid and alkali, it may decompose or degrade, thereby affecting its biological activity and efficacy. Therefore, during storage and transportation, it needs to be kept in a dry and cool environment to ensure its quality and stability.

In terms of synthesis methods, there are currently three main methods: chemical synthesis, enzyme-catalyzed synthesis, and fermentation. The chemical synthesis method is to construct the molecular structure of NMN through chemical reagents and reaction steps. This method has the advantages of high production efficiency and relatively low cost, but there may be more impurities and complex separation and purification processes. The enzyme-catalyzed synthesis method uses specific enzymes as catalysts to convert substrates into NMN under relatively mild reaction conditions. This method has the advantages of high reaction specificity and high product purity, but the high cost of enzyme preparation limits its large-scale production. The fermentation method is to produce NMN by microbial fermentation. This method is green and environmentally friendly and has high product safety, but the fermentation process is difficult to control and the yield increase also faces certain challenges.

NMN has many important physiological functions in the body. It is the direct precursor of NAD⁺, and supplementing NMN can effectively increase the level of NAD⁺ in the body. As an important coenzyme, NAD⁺ participates in many key physiological processes such as intracellular energy metabolism, DNA repair, and gene expression regulation. As we age, the level of NAD⁺ in the human body will gradually decrease, leading to the decline of cell function and an increased risk of various aging-related diseases. By supplementing NMN to increase the level of NAD⁺, it is expected to delay the aging process and improve physiological functions related to aging, such as enhancing energy metabolism, improving immunity, and improving cognitive function. In addition, NMN also shows potential application value in the prevention and treatment of some diseases, such as cardiovascular disease and neurodegenerative diseases.

In the application field, NMN is mainly used in the health care products and cosmetics industries. In the field of health care products, NMN is made into various oral preparations, such as capsules and tablets. As a new type of anti-aging health care product, it has received widespread attention from consumers. In the cosmetics industry, NMN is added to skin care products to promote cell metabolism and enhance skin barrier function, achieving anti-wrinkle, whitening, moisturizing and other skin care effects. In addition, NMN also has broad application prospects in the field of medical research and development. A number of clinical trials are currently being carried out to explore its effectiveness and safety in the treatment of various diseases.

Although NMN has great application potential, its development is still facing some challenges and controversies. On the one hand, the safety and long-term effectiveness of NMN still need more clinical studies to confirm, and its metabolic pathways and mechanisms of action in the human body also need to be further explored. On the other hand, the high production cost of NMN limits its large-scale application and market penetration. In addition, there are some NMN products of varying quality on the market, and the lack of effective supervision and quality standards has also caused trouble for consumers' choices. In the future, with the continuous deepening of research and the continuous advancement of technology, NMN is expected to be used in more fields and bring more benefits to human health and life, but at the same time, it is also necessary to strengthen supervision and quality control to ensure its safe and effective application in the market.

Report Scope
This report aims to deliver a thorough analysis of the global market for Nicotinamide Mononucleotide (NMN), offering both quantitative and qualitative insights to assist readers in formulating business growth strategies, evaluating the competitive landscape, understanding their current market position, and making well-informed decisions regarding Nicotinamide Mononucleotide (NMN).

The report is enriched with qualitative evaluations, including market drivers, challenges, Porter’s Five Forces, regulatory frameworks, consumer preferences, and ESG (Environmental, Social, and Governance) factors.

The report provides detailed classification of Nicotinamide Mononucleotide (NMN), such as type, etc.; detailed examples of Nicotinamide Mononucleotide (NMN) applications, such as application one, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report provides detailed classification of Nicotinamide Mononucleotide (NMN), such as Content ≥98%, Content ＜98%, etc.; detailed examples of Nicotinamide Mononucleotide (NMN) applications, such as Health Care Products, Cosmetics, Others, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report covers key global regions—North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa—providing granular, country-specific insights for major markets such as the United States, China, Germany, and Brazil.

The report deeply explores the competitive landscape of Nicotinamide Mononucleotide (NMN) products, details the sales, revenue, and regional layout of some of the world's leading manufacturers, and provides in-depth company profiles and contact details.

The report contains a comprehensive industry chain analysis covering raw materials, downstream customers and sales channels.

Core Chapters

Chapter One: Introduces the study scope of this report, market status, market drivers, challenges, porters five forces analysis, regulatory policy, consumer preference, market attractiveness and ESG analysis.

Chapter Two: market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Nicotinamide Mononucleotide (NMN) market sales and revenue in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter Four: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Five: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales, revenue, market share, footprint, merger, and acquisition information, etc.

Chapter Six: Provides profiles of leading manufacturers, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction.

Chapter Seven: Analysis of industrial chain, key raw materials, customers and sales channel.

Chapter Eight: Key Takeaways and Final Conclusions

Chapter Nine: Methodology and Sources.

1 Nicotinamide Mononucleotide (NMN) Market Overview and Qualitative Analysis
1.1 Nicotinamide Mononucleotide (NMN) Product Definition and Statistical Scope
1.2 Nicotinamide Mononucleotide (NMN) Market Status and Outlook
1.2.1 Nicotinamide Mononucleotide (NMN) Market Revenue Estimates and Forecasts 2020-2031
1.2.2 Nicotinamide Mononucleotide (NMN) Market Sales Estimates and Forecasts 2020-2031
1.3 Nicotinamide Mononucleotide (NMN) Market Driver Analysis
1.4 Nicotinamide Mononucleotide (NMN) Market Challenges Analysis
1.5 Porter's Five Forces Analysis
1.5.1 Bargaining Power of Suppliers
1.5.2 Bargaining Power of Buyers/Consumers
1.5.3 Threat of New Entrants
1.5.4 Threat of Substitute Products
1.5.5 Intensity of Competitive Rivalry
1.6 Regulatory Policy Analysis
1.7 Consumer Preference Analysis
1.8 Market Attractiveness Analysis
1.9 ESG (Environmental, Social and Governance) Analysis
2 Nicotinamide Mononucleotide (NMN) Market Type Estimates & Trend Analysis
2.1 Nicotinamide Mononucleotide (NMN) Type Dashboard
2.2 Nicotinamide Mononucleotide (NMN) Market by Type
2.2.1 Content ≥98%
2.2.2 Content ＜98%
2.3 Global Nicotinamide Mononucleotide (NMN) Market Size by Type
2.3.1 Historical Analysis of the Global Nicotinamide Mononucleotide (NMN) Market Size by Type (2020-2025)
2.3.2 Projected Analysis of Global Nicotinamide Mononucleotide (NMN) Market Size by Type (2026–2031)
3 Nicotinamide Mononucleotide (NMN) Market Geography Estimates & Trend Analysis
3.1 Nicotinamide Mononucleotide (NMN) Geography Dashboard
3.2 Global Nicotinamide Mononucleotide (NMN) Historic Market Size by Region
3.2.1 Global Nicotinamide Mononucleotide (NMN) Market Sales by Region (2020-2025)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2020-2025)
3.3 Global Nicotinamide Mononucleotide (NMN) Forecasted Market Size by Region
3.3.1 Global Nicotinamide Mononucleotide (NMN) Market Sales by Region (2026-2031)
3.3.2 Global Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2026-2031)
3.4 North America Nicotinamide Mononucleotide (NMN) Market by Country
3.4.1 North America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2031)
3.4.2 North America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2031)
3.4.3 United States Nicotinamide Mononucleotide (NMN) Market Sales, Revenue and Growth Rate (2020-2031)
3.4.4 Canada Nicotinamide Mononucleotide (NMN) Market Sales, Revenue and Growth Rate (2020-2031)
3.5 Europe Nicotinamide Mononucleotide (NMN) Market by Country
3.5.1 Europe Nicotinamide Mononucleotide (NMN) Market Sale by Country (2020-2031)
3.5.2 Europe Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2031)
3.5.3 Germany Market Sales, Revenue and Growth Rate (2020-2031)
3.5.4 France Market Sales, Revenue and Growth Rate (2020-2031)
3.5.5 U.K. Market Sales, Revenue and Growth Rate (2020-2031)
3.5.6 Italy Market Sales, Revenue and Growth Rate (2020-2031)
3.5.7 Spain Market Sales, Revenue and Growth Rate (2020-2031)
3.6 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market by Region
3.6.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Sales by Region (2020-2031)
3.6.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2020-2031)
3.6.3 China Market Sales, Revenue and Growth Rate (2020-2031)
3.6.4 Japan Market Sales, Revenue and Growth Rate (2020-2031)
3.6.5 South Korea Market Sales, Revenue and Growth Rate (2020-2031)
3.6.6 India Market Sales, Revenue and Growth Rate (2020-2031)
3.6.7 Southeast Asia Market Sales, Revenue and Growth Rate (2020-2031)
3.7 Latin America Nicotinamide Mononucleotide (NMN) Market by Country
3.7.1 Latin America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2031)
3.7.2 Latin America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2031)
3.7.3 Mexico Market Sales, Revenue and Growth Rate (2020-2031)
3.7.4 Brazil Market Sales, Revenue and Growth Rate (2020-2031)
3.8 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market by Country
3.8.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2031)
3.8.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2031)
3.8.3 Turkey Market Sales, Revenue and Growth Rate (2020-2031)
3.8.4 Saudi Arabia Market Sales, Revenue and Growth Rate (2020-2031)
3.8.5 South Africa Market Sales, Revenue and Growth Rate (2020-2031)
4 Nicotinamide Mononucleotide (NMN) Market Application Estimates & Trend Analysis
4.1 Nicotinamide Mononucleotide (NMN) Market Application Dashboard
4.2 Nicotinamide Mononucleotide (NMN) Market by Application
4.2.1 Health Care Products
4.2.2 Cosmetics
4.2.3 Others
4.3 Global Nicotinamide Mononucleotide (NMN) Market Size by Application
4.3.1 Historical Analysis of Global Nicotinamide Mononucleotide (NMN) Market Size by Application (2020-2025)
4.3.2 Projected Analysis of Global Nicotinamide Mononucleotide (NMN) Market Size by Application (2026-2031)
5 Nicotinamide Mononucleotide (NMN) Market Competitive Landscape Analysis
5.1 Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Sales Performance and Share Analysis
5.2 Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Revenue Performance and Share Analysis
5.3 Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Average Sales Price (2020-2025)
5.4 Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Regional Footprint (Headquarters, Manufacturing Base and Sales Ares)
5.5 Mergers and Acquisition Analysis
6 Leading Manufacturers’ Company Profiles
6.1 GeneHarbor
6.1.1 GeneHarbor Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.1.2 GeneHarbor Introduction and Business Overview
6.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio
6.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.2 Herbalmax
6.2.1 Herbalmax Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.2.2 Herbalmax Introduction and Business Overview
6.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio
6.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.3 Genex Formulas
6.3.1 Genex Formulas Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.3.2 Genex Formulas Introduction and Business Overview
6.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
6.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.4 Mirailab Bioscience
6.4.1 Mirailab Bioscience Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.4.2 Mirailab Bioscience Introduction and Business Overview
6.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Portfolio
6.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.5 Maac10 Formulas
6.5.1 Maac10 Formulas Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.5.2 Maac10 Formulas Introduction and Business Overview
6.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
6.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.6 EffePharm
6.6.1 EffePharm Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.6.2 EffePharm Introduction and Business Overview
6.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio
6.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.7 Bontac
6.7.1 Bontac Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.7.2 Bontac Introduction and Business Overview
6.7.3 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio
6.7.4 Bontac Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.8 CELFULL
6.8.1 CELFULL Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.8.2 CELFULL Introduction and Business Overview
6.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio
6.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.9 Kingdomway
6.9.1 Kingdomway Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.9.2 Kingdomway Introduction and Business Overview
6.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio
6.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.10 ABA Chemical
6.10.1 ABA Chemical Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.10.2 ABA Chemical Introduction and Business Overview
6.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Product Portfolio
6.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
7 Industry Chain Analysis
7.1 Upstream Key Raw Materials
7.1.1 Raw Materials A Definition and Suppliers
7.1.2 Raw Materials B Definition and Suppliers
7.1.3 Raw Materials C Definition and Suppliers
7.2 Nicotinamide Mononucleotide (NMN) Typical Downstream Customers
7.3 Nicotinamide Mononucleotide (NMN) Sales Channel Analysis
8 Key Takeaways and Final Conclusions
9 Methodology and Sources
9.1 Research Methodology
9.2 Data Mining
9.2.1 Preliminary Data Sources
9.2.2 Secondary Sources
9.3 Industry Analysis Matrix
9.4 Disclaimer

Table 1. Nicotinamide Mononucleotide (NMN) Market Driver Analysis
Table 2. Nicotinamide Mononucleotide (NMN) Market Challenges Analysis
Table 3. Nicotinamide Mononucleotide (NMN) Regulatory Policy Analysis
Table 4. Nicotinamide Mononucleotide (NMN) Consumer Preference Analysis
Table 5. Nicotinamide Mononucleotide (NMN) Market Attractiveness Analysis
Table 6. Nicotinamide Mononucleotide (NMN) ESG Analysis
Table 7. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Type: 2020 VS 2024 VS 2031
Table 8. Global Nicotinamide Mononucleotide (NMN) Market Sales by Type (2020-2025)
Table 9. Global Nicotinamide Mononucleotide (NMN) Market Sales Share by Type (2020-2025)
Table 10. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Type (2020-2025)
Table 11. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Type (2020-2025)
Table 12. Global Nicotinamide Mononucleotide (NMN) Market Price by Type (2020-2025)
Table 13. Global Nicotinamide Mononucleotide (NMN) Market Sales by Type (2026-2031)
Table 14. Global Nicotinamide Mononucleotide (NMN) Market Sales Share by Type (2026-2031)
Table 15. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Type (2026-2031)
Table 16. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Type (2026-2031)
Table 17. Global Nicotinamide Mononucleotide (NMN) Market Price by Type (2026-2031)
Table 18. Global Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region: 2020 VS 2024 VS 2031
Table 19. Global Nicotinamide Mononucleotide (NMN) Market Sales by Region (2020-2025)
Table 20. Global Nicotinamide Mononucleotide (NMN) Market Sales Share by Region (2020-2025)
Table 21. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2020-2025)
Table 22. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Region (2020-2025)
Table 23. Global Nicotinamide Mononucleotide (NMN) Market Sales by Region (2026-2031)
Table 24. Global Nicotinamide Mononucleotide (NMN) Market Sales Share in Volume by Region (2026-2031)
Table 25. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2026-2031)
Table 26. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Region (2026-2031)
Table 27. North America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2025)
Table 28. North America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2026-2031)
Table 29. North America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2025)
Table 30. North America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2026-2031)
Table 31. Europe Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2025)
Table 32. Europe Nicotinamide Mononucleotide (NMN) Market Sales by Country (2026-2031)
Table 33. Europe Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2025)
Table 34. Europe Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2026-2031)
Table 35. Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Sales by Region (2020-2025)
Table 36. Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Sales by Region (2026-2031)
Table 37. Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2020-2025)
Table 38. Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Revenue by Region (2026-2031)
Table 39. Latin America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2025)
Table 40. Latin America Nicotinamide Mononucleotide (NMN) Market Sales by Country (2026-2031)
Table 41. Latin America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2025)
Table 42. Latin America Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2026-2031)
Table 43. Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Sales by Country (2020-2025)
Table 44. Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Sales by Country (2026-2031)
Table 45. Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2020-2025)
Table 46. Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Revenue by Country (2026-2031)
Table 47. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Application: 2020 VS 2024 VS 2031
Table 48. Global Nicotinamide Mononucleotide (NMN) Market Sales by Application (2020-2025)
Table 49. Global Nicotinamide Mononucleotide (NMN) Market Sales Share by Application (2020-2025)
Table 50. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Application (2020-2025)
Table 51. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Application (2020-2025)
Table 52. Global Nicotinamide Mononucleotide (NMN) Market Price by Application (2020-2025)
Table 53. Global Nicotinamide Mononucleotide (NMN) Market Sales by Application (2026-2031)
Table 54. Global Nicotinamide Mononucleotide (NMN) Market Sales Share by Application (2026-2031)
Table 55. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Application (2026-2031)
Table 56. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Application (2026-2031)
Table 57. Global Nicotinamide Mononucleotide (NMN) Market Price by Application (2026-2031)
Table 58. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Sales Performance
Table 59. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Sales Share
Table 60. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Revenue Performance (2020-2025)
Table 61. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Market Revenue Share (2020-2025)
Table 62. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Average Sales Price (2020-2025)
Table 63. Global Nicotinamide Mononucleotide (NMN) Leading Manufacturers’ Regional Footprint (Headquarters, Manufacturing Base and Sales Areas)
Table 64. Mergers and Acquisition Analysis
Table 65. GeneHarbor Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 66. GeneHarbor Introduction and Business Overview
Table 67. GeneHarbor Nicotinamide Mononucleotide (NMN) Product
Table 68. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 69. Herbalmax Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 70. Herbalmax Introduction and Business Overview
Table 71. Herbalmax Nicotinamide Mononucleotide (NMN) Product
Table 72. Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 73. Genex Formulas Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 74. Genex Formulas Introduction and Business Overview
Table 75. Genex Formulas Nicotinamide Mononucleotide (NMN) Product
Table 76. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 77. Mirailab Bioscience Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 78. Mirailab Bioscience Introduction and Business Overview
Table 79. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product
Table 80. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 81. Maac10 Formulas Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 82. Maac10 Formulas Introduction and Business Overview
Table 83. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product
Table 84. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 85. EffePharm Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 86. EffePharm Introduction and Business Overview
Table 87. EffePharm Nicotinamide Mononucleotide (NMN) Product
Table 88. EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 89. Bontac Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 90. Bontac Introduction and Business Overview
Table 91. Bontac Nicotinamide Mononucleotide (NMN) Product
Table 92. Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 93. CELFULL Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 94. CELFULL Introduction and Business Overview
Table 95. CELFULL Nicotinamide Mononucleotide (NMN) Product
Table 96. CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 97. Kingdomway Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 98. Kingdomway Introduction and Business Overview
Table 99. Kingdomway Nicotinamide Mononucleotide (NMN) Product
Table 100. Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 101. ABA Chemical Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 102. ABA Chemical Introduction and Business Overview
Table 103. ABA Chemical Nicotinamide Mononucleotide (NMN) Product
Table 104. ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 105. Raw Materials A Key Suppliers Lists
Table 106. Raw Materials B Key Suppliers Lists
Table 107. Raw Materials C Key Suppliers Lists
Table 108. Nicotinamide Mononucleotide (NMN) Typical Downstream Customers
Table 109. Research Programs/Design for This Report
Figure 1. Nicotinamide Mononucleotide (NMN) Product Picture
Figure 2. Global Nicotinamide Mononucleotide (NMN) Market Size, 2020 VS 2024 VS 2031
Figure 3. Global Nicotinamide Mononucleotide (NMN) Market Size Status and Outlook (2020-2031)
Figure 4. Global Nicotinamide Mononucleotide (NMN) Sales Status and Outlook (2020-2031)
Figure 5. Nicotinamide Mononucleotide (NMN) Porter's Five Forces Analysis Picture
Figure 6. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Type (2020-2031)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Market Revenue Share by Type in 2024 & 2031
Figure 8. Product Picture of Content ≥98%
Figure 9. Global Content ≥98% Revenue and Growth Rate (2020-2031)
Figure 10. Product Picture of Content ＜98%
Figure 11. Global Content ＜98% Revenue and Growth Rate (2020-2031)
Figure 12. United States Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 13. United States Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 14. Canada Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 15. Canada Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 16. Germany Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 17. Germany Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 18. France Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 19. France Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 20. U.K. Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 21. U.K. Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 22. Italy Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 23. Italy Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 24. Spain Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 25. Spain Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 26. China Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 27. China Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 28. Japan Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 29. Japan Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 30. South Korea Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 31. South Korea Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 32. India Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 33. India Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 34. Southeast Asia Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 35. Southeast Asia Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 36. Mexico Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 37. Mexico Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 38. Brazil Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 39. Brazil Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 40. Turkey Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 41. Turkey Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 42. Saudi Arabia Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 43. Saudi Arabia Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 44. South Africa Nicotinamide Mononucleotide (NMN) Market Sales and Growth Rate (2020-2031)
Figure 45. South Africa Nicotinamide Mononucleotide (NMN) Market Revenue and Growth Rate (2020-2031)
Figure 46. Global Nicotinamide Mononucleotide (NMN) Market Revenue by Application (2020-2031)
Figure 47. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2024 & 2031
Figure 48. Product Picture of Health Care Products
Figure 49. Global Health Care Products Revenues YoY Growth (2020-2031)
Figure 50. Product Picture of Cosmetics
Figure 51. Global Cosmetics Revenues YoY Growth (2020-2031)
Figure 52. Product Picture of Others
Figure 53. Global Others Revenues YoY Growth (2020-2031)
Figure 54. Nicotinamide Mononucleotide (NMN) Channels of Distribution (Direct Vs Distribution)